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Abstract
Muscle strength as a proxy for muscle function has emerged as a predictor of nutritional
status in both clinical as well as epidemiological studies. Hand grip strength (HGS) is a
reliable non-invasive test of muscle strength. Dynapenia (weak strength) is
independently associated with loss of physical functionality, quality of life (QoL)
characteristics and reduced survival. The first aim of this study was to investigate the
prevalence of dynapenia using handgrip strength (HGS) in ambulatory oncology patients
and to determine if this had an impact on quality of life (QoL). This prospective crosssectional study was conducted in the oncology day ward and outpatient clinic in Sligo
University Hospital (SUH). To assess QoL, participants completed the European
Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core
30 (EORTC QLQ-C30). Isometric handgrip dynamometry was used to determine muscle
strength of the dominant forearm. Three measures were performed, and the highest value
was analysed. Weak handgrip strength was defined as <27kg for males and <16kg for
females. Statistical analysis was conducted using SPSS version 26.0. The cohort (n=160)
was predominantly female (58.1%) and breast cancer was the most prevalent cancer type
(29.4%). The mean age was 63.2 ± 11.3 years. Over half of the cohort was overweight
(53.5%) and 70% had not received nutritional advice from a dietician, with 77.5%
reporting weight changes since diagnosis. Weak handgrip strength was present in 26.9%
of the cohort. Weaker HGS was significantly associated with poorer QoL, physical, role,
emotional and cognitive functioning (p < 0.001). Additionally, weaker HGS was
associated with increased symptom scale scores for fatigue, pain, and appetite loss (p <
0.001). Results display how poor muscular strength impacts QoL in an ambulatory
oncology setting in the North-West of Ireland. The impact of screening weak muscle
strength by grip strength should assessed. This has the potential to aid timely referral to
nutrition support or resistance training, which could lead to improvement of muscle
strength, maintaining functional independence, and subsequently enhancing quality of
life.
Keywords: Cancer; Muscle Strength; Protein malnutrition; Hand-grip Strength; Quality
of life

Published by ARROW@TU Dublin, 2021

1

SURE_J: Science Undergraduate Research Journal, Vol. 3, Iss. 1 [2021], Art. 4

Science Undergraduate Research Experience
Volume (3), Issue (1)

O’Callaghan, O’Sullivan, McHugh and Keaver

1. Introduction
Worldwide, the association between malnutrition and cancer has become a major
concern. The prevalence of malnutrition in oncology varies, with estimates from 8-85%,
dependent on tumour site and definition (Kruizenga et al., 2016; Martin et al., 2015). The
Global Leadership Initiative on Malnutrition (GLIM) recently developed criteria for the
diagnosis of malnutrition (de van der Schueren et al., 2020). The criteria states at least
one phenotypic criterion and one etiologic criterion should be present. The authors of
these guidelines indicated that reduced muscle is a strong phenotypic criterion with
strong evidence to support its inclusion in the diagnostic malnutrition criteria.
Specifically, as low muscle mass is associated with several negative clinical outcomes,
such as an increased risk of readmission, longer hospital stays, disability, reduced
functional capacity, loss of independence, and higher risk of mortality (Deutz et al., 2019;
Gariballa and Alessa, 2017).
Given the shortcomings of using BMI and weight loss to accurately assess body
composition (Deutz et al., 2019), there are a number of alternative, complementary tools
and techniques available that can be used. There are a variety of ways to measure fat-free
mass, the consensus proposes several techniques that were validated, such as dual-energy
X-ray absorptiometry, bioelectrical impedance analysis, computed tomography, or
magnetic resonance imaging. Nonetheless, each technique varies both in precision and
availability and often these techniques may not be available at the bedside and it is
important to consider alternative muscle measures.
A recent Irish review by Ryan and co-workers (2019), focused on muscle degradation in
oncology and its correlation with reduced quality of life concluded with the authors
emphasising the need for routine and cost-effective methods of measuring muscle in
clinical settings. While measuring muscle mass can be expensive and not as routinely
feasible, the measurement of muscle strength by hand-grip strength (HGS) is simple and
has been rigorously tested in other clinical cohorts (Leal et al. 2010). Muscle strength as
a proxy of muscle function has been widely utilized in both clinical as well as
epidemiological studies as a prognostic marker (Kerr et al., 2006; Newman et al., 2006).
Measuring grip strength is economical, non-invasive, and convenient for clinical settings
(Bohannon 2015). If muscle strength declines first, before muscle mass and weight loss,
as suggested by (Norman et al., 2011), it has the capability of identifying patients at risk
of malnutrition (Flood et al., 2014). It could aid timely referral to nutrition support, thus
aiding in the improvement of muscle strength, reduced length of hospital stays
(Kruizenga et al., 2016), improved tolerance to treatment (Capuano et al., 2010), and
subsequently improved quality of life (QoL).
Dynapenia refers to the loss of muscular strength (Manini and Clark, 2011). Dynapenia
as part of the pathogenesis occurs when tumour secretes pro-inflammatory cytokines,
which can alter the molecular pathways resulting in muscle degradation (Burckart et al.,
2010). In oncology patients, dynapenia can be multifactorial, it can be part of the
pathogenesis of malignant tumour (Sanders and Tisdale, 2004), a feature of a muscle
abnormality (Norman et al., 2015), an effect of the treatment prescribed (Klassen et al.,
2017) or a consequence of cancer-related fatigue and consequent inactivity (Kilgour et
al., 2010). Additionally, it can be a response to various non-cancer specific factors that
are all influential on muscle weakness, including ageing, malnutrition, and lack of
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physical activity (Lycke et al., 2019; Kilgour et al., 2013; Ceseiko et al., 2019). A loss of
muscle mass can impact activities of daily living and consequently has the potential to
worsen nutritional status.
In view of the above, this research project aimed to investigate the prevalence of weak
HGS in ambulatory oncology patients in the West of Ireland. A further aim was to explore
the relationship between weak HGS and quality of life in this group. A better
understanding of this relationship would inform more practical ways to diagnose the
nutritional status of ambulatory oncology patients.

2. Materials and Methods
Ethical Approval
Ethical approval was granted by the Research and Education Foundation Ethics
Committee at Sligo University Hospital.
Study design
This prospective cross-sectional study was conducted in Sligo University Hospital (SUH)
between September and December 2019.
Participants
All adult (≥18 years) ambulatory patients, who were attending the oncology day ward or
oncology outpatient clinic were invited to participate in the study. An information sheet
explaining what the study entailed was provided for each participant. The participants
were reminded that participation in the study was voluntary, and any questions were
addressed. Informed signed consent was obtained before the commencement of data
collection.
Data collection
Questionnaires
A general questionnaire (thirteen questions) collected demographic data (age, gender,
living situation, education, employment) and oncology specific data, (cancer type,
current or previous treatment, time since diagnosis). The European Organisation for
Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC QLQC30) was used to determine QoL. It is a multidimensional questionnaire used to assess
the QoL of cancer patients which includes thirteen multiple item scales. This includes an
overall global health/ QoL scale, five functional scales (physical, role, cognitive,
emotional, and social), seven patient symptom scales (fatigue, pain, nausea, vomiting,
etc) and a financial burden scale. The EORTC QLQ-C30 subscales were calculated
according to the EORTC QLQ-C30 manual and received a score from 0 to 100 (Fayers
et al. 2001). For the global health status/ QoL scale and the five functional scales, a higher
score indicates a higher level of quality of life and functioning. Higher scores on the
seven symptom scales and the financial impact scale represent more of an impact of these
symptom classes. The questionnaires were completed independently by the participants,
however, if the participants needed assistance to complete the questionnaire, the
questions were read to the individuals and the responses were recorded on the
questionnaire by the researcher.
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Anthropometry
Weight and height of all those who agreed to participate in the study were recorded by
the oncology nurse. Weight was measured to the nearest 0.1 kg using a column weighing
scales (Seca). Height was measured using a Seca portable stadiometer and was rounded
to the nearest cm, the height in cm was then converted to m2 by the researcher. BMI was
calculated using the formula kg/m2. BMI was classified as per World Health
Organization guidelines (WHO, 2020.): < 18.5 kg/m2 considered as underweight; > 18.5
kg/m2 and < 25 kg/m2considered as healthy weight; ≥ 25 kg/m2 and < 30 kg/m2
considered as overweight; and ≥ 30 kg/m2 considered as obese.
Handgrip - strength
Isometric handgrip dynamometry measures the maximum isometric strength of the hand
and forearm muscles. Isometric hand grip strength is strongly related with lower
extremity muscle power, knee extension torque and calf cross-sectional muscle area
(Cruz-Jentoft et al., 2010). In our study, a spring-loaded, handgrip dynamometer (Takei
5001 Hand Grip Dynamometer-Grip A) determined isometric force of the forearm. Prior
to the test being carried out, the researcher demonstrated to the participant how the test
is performed, along with verbal instructions on how to conduct the test. Participants were
seated with their feet fully on the floor and their shoulder neutrally rotated. The dominant
arm was placed at a 90° angle with their elbow held close to their body. The dynamometer
handle remained in position 2 unless the participant required this to be altered to make
holding the device more comfortable. The base rested on the heel of the palm of the
dominant hand, whereas the handle rested on middle of the four fingers. The nondominant hand rested beside the body. When participants were ready, the dynamometer
was squeezed with maximum isometric effort, and this was maintained for 3 s. Each
participant was given one practice attempt first to get used to the device and then three
measures using the dominant hand were recorded. Participants were instructed to restrict
other body movement and to give maximal effort for each attempt. The test was repeated
within 30 s and values reached were recorded to the nearest 0.5 kg. Weak muscle strength
(dynapenia) was defined as a handgrip <27 kg for men and <16 kg for women (CruzJentoft et al., 2018).
Statistical Analysis
Statistical analysis was performed using the statistical package for social science (SPSS
- version 26.0, 2019, SPSS Inc., Chicago, IL, USA). The mean ± SD is presented for
continuous data, the frequency and percentage for categorical data and the medians and
interquartile range (IQR) for non-normally distributed data. HGS data was not normally
distributed as tested by Shapiro–Wilk’s test and therefore a non-parametric test (MannWhitney) was used. To test for associations between variables chi-squared was used for
categorical data, one-way analysis of variance for normally distributed continuous data
and Mann–Whitney tests for continuous data that were not normally distributed
(Cognitive and Social Functioning). Student’s Independent Samples T-test was used to
test statistical significance of normally distributed QoL scales between the two HGS
groups. Levene’s test determined that the assumption of homogeneity of variance was
met. Bonferroni adjusted p-values were used for all post-hoc tests. All statistical tests
were two‐sided, and p‐values are reported to two decimal places. Significance was taken
at the level of p < 0.05.
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3. Results
In total, 160 individuals were recruited, overall, an 85.3% response rate. The cohort was
predominantly female (n= 94, 58.1%), with breast cancer as the most prevalent cancer
type (n=47, 29.4%), followed by colorectal malignancies (20.4%). The age range was
34-83 years old, with a mean age of 63.2±11.3 years. Nearly half of the cohort were
retired (n=75, 46.9%). Mean BMI was 26.7 ± 6.0 kg m2 and over half of the respondents
were classified as overweight or obese (n=94, 53.3%). Recent weight loss (within
previous six months) was reported by 37.5% of the cohort (n = 60), with weight gain
being reported in an additional 40% (n = 64). Over two thirds of the cohort were
receiving chemotherapy treatment and near to one third were not receiving any treatment.
From the total cohort, 26.9% (n=43) of patients had dynapenia. Between the normal and
weak HGS groups, there was a statistical significance difference in strength, (p<0.001).
Predominantly, those who had weak HGS were in the 70+ age category (n=19, 45.3)
and consisted of patients who were still receiving treatment (Table 1).
Table 1: Demographic and clinical characteristics of the study cohort and broken down by normal HGS
and weak HGS (dynapenia).

Total
n = 160

Normal HGS
n = 117

Weak HGS
(dynapenia)
n= 43

66 (41.9)

47 (40.2)

19 (45.2)

94 (58.1)

70 (59.8)

24 (54.8)

160

63.2±11.3

62.5±11

65.2±12.1

34-49
50-59
60-69
70+

160

15 (9.4)
48 (30.0)
41 (25.6)
56 (35.0)

11 (9.4)
38 (32.5)
31 (26.5)
37 (31.6)

4 (9.5)
10 (23.8)
10 (21.4)
19 (45.3)

Handgrip strength (kg)
Median (IQR)

160

25 (14)

30 (12)

20 (7.0) *

159

3.9±4.8

3.8±4.9

4.2±4.5

159

47 (29.4)
32 (20.0)
21 (13.1)
17 (10.6)
14 (8.8)

33 (28.2)
24 (20.5)
11 (9.4)
14 (12.0)
11 (9.4)

14 (33.3)
8 (19.0)
10 (23.8)
3 (7.1)
3 (4.8)

Demographics

Gender
n (%)

Male
160
Female

Age (years), Mean (SD)
Age group
(years)
n (%)

Time from diagnosis (years), Mean
(SD)
Breast
Colorectal
Primary tumor,
Hematologic
n (%)
Upper GI
Lung
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Education
completed
n (%)
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Gynecologic
Prostate +
Testicular
Other
Chemotherapy
Radiotherapy
Hormonal
Therapy
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13 (8.1)

11 (9.4)

2 (4.8)

9 (5.7)

3 (7.7)

0 (0.0)

6 (3.8)
100 (62.6)
8 (5.0)

4 (3.4)
72 (62.4)
6 (4.3)

2 (7.2)
26 (60.5)
2 (4.7)

17 (10.6)

12 (7.7)

5 (11.6)

40 (25.0)

30 (25.6)

10 (23.2)

Less than second
level

31 (19.5)

16 (9.4)

15 (35.7)

Completed
second level
Bachelor’s
Degree
Graduate School
(Master’s/Doctor
ate)

82 (52.2)

62 (36.3)

20 (47.6)

35 (22.0)

28 (16.3)

7 (16.7)

10 (6.3)

10 (5.85.8)

0 (0.0)

40 (25.0)

32 (27.4)

8 (19)

7 (4.4)
14 (8.8)
8 (5.0)
75 (46.9)
16 (10.0)

4 (3.4)
10 (8.5)
6 (5.1)
53 (45.3)
12 (10.3)

3 (7.1)
4 (9.5)
2 (2.4)
22 (52.4)
4 (9.5)

26.7±6.0

27±6.3

25.3±5.1

9 (5.8)

5 (4.4)

4 (10.0)

51 (33.1)

34 (30.1)

17 (40.0)

61 (31.9)
33 (21.4)

50 (44.2)
24 (21.2)

11 (27.5)
9 (22.5)

160

60 (37.5)

45 (38.5)

14 (33.3)

160

64 (40.0)

45 (38.5)

19 (45.2)

160

48 (30.0)

36 (30.8)

12 (28.6)

160

No current
treatment

Full-time
Part-time
Unemployed
Homemaker
Retired
Sick Leave

BMI (kg/m2), Mean (SD)
Underweight
Healthy
BMI
Weight
classification, n
(%)
Overweight
Obese
Experienced weight loss in last 6
months, n (%)
Experienced weight gain in last 6
months, n (%)
Seen or been referred to a dietitian,
n (%)

158

160

154

154

a

Several patients were receiving more than one type of current treatment; therefore, the total is ≠ to
100%.
* A Mann-Whitney U test indicated a statistical significance between HGS groups (p<0.001)
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Table 2 shows for both genders there was a significance between the first three quartiles
and 100th HGS quartile (p <0.001). Additionally, there was a statistical significance in
HGS for each quartile (p <0.001).
Table 2: Demographic and clinical characteristics presented by HGS quartiles.

Demographics

Gender
n (%)

n

6 (18.2)

21 (55.3)

30 (83.3) *

43 (81.1)

27 (81.1)

17 (44.7)

6 (16.7) *

160

65.2±12.6

60.0±9.2

61.7±12.2

64.0±9.5

160

7 (13.2)
11 (20.8)
8 (15.1)
27 (50.1)

3 (9.1)
13 (39.4)
12 (36.4)
5 (15.1)

4 (10.5)
15 (39.5)
7 (18.4)
12 (31.5)

1 (2.8)
9 (25.0)
13 (36.1)
13 (36.1)

23 (3.0) **

29.5 (3.0)**

38 (9.0) **

3.9±4.0

2.8±2.6

3.9±4.4

4.5±6.4

21 (40.4)
3 (5.8)
7 (13.3)
5 (9.5)
7 (13.3)
4 (7.7)

14 (42.4)
5 (15.2)
1 (3.0)
3 (9.1)
5 (15.2)
4 (12.0)

11 (28.9)
9 (23.9)
8 (20.8)
3 (7.8)
2 5.2)
1 (2.6)

1 (2.8)
16 (44.4)
5 (14.0)
6 (16.6)
0 (0.0)
2 (5.6)

3 (5.8)

1 (3.0)

1 (2.6)

4 (11.1)

2 (3.8)
31 (58.5)
4 (7.6)

0 (0.0)
25 (75.8)
2 (6.0)

3 (7.8)
22 (57.9)
0 (0.0)

2 (5.6)
22 (55.6)
2 (5.6)

7 (13.2)

4 (12.1)

5 (13.2)

1 (2.8)

14 (26.4)

4 (12.1)

11 (28.9)

11 (30.8)

15 (28.3)

3 (12.5)

5 (13.2)

8 (22.2)

160

Age (years), Mean (SD)
34-49
50-59
60-69
70+

Handgrip strength (kg)
Median (IQR)
Time from diagnosis (years),
Mean (SD)
Breast
Colorectal
Hematologic
Upper GI
Primary tumor,
Lung
n (%)
Gynecologic
Prostate +
Testicular
Other
Chemotherapy
Radiotherapy
Current
Hormonal
treatments (a)
Therapy
n (%)
No current
treatment

160 18 (4.0) **
159

159

160

158
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Less than
second level
Completed
second level
Bachelor’s
Degree
Graduate
School
(Master’s/Doct
orate)
Full-time
Part-time
Unemployed
Homemaker
Retired
Sick Leave

BMI (kg/m2), mean (SD)
Underweight
Healthy
BMI
Weight
classification,
n (%)
Overweight
Obese
Experienced weight loss in last 6
months, n (%)
Experienced weight gain in last
6 months, n (%)
Seen or been referred to a
dietitian, n (%)

160

154

23 (43.4)

15 (46.9)

22 (57.9)

22 (61.1)

13 (24.5)

11 (34.4)

7 (18.4)

4 (11.1)

2 (3.8)

2 (6.3)

4 (10.5)

2 (5.6)

6 (11.3)

12 (36.3)

14 (36.8)

8 (22.2)

2 (3.8)
5 (9.4)
1 (1.9)
32 (60.4)
7 (13.2)

2 (6.1)
2 (6.1)
4 (12.1)
10 (30.3)
3 (9.1)

2 (5.3)
2 (5.3)
1 (2.6)
15 (39.5)
4 (10.5)

1 (2.8)
5 (13.9)
1 (2.8)
19 (52.8)
2 (5.6)

26.3±7.1

28.2±3.5

25.8±6.5

27.0±6.4

6 (11.5)

0 (0.0)

2 (5.3)

0 (0.0)

17 (32.7)

16 (48.5)

12 (31.6)

6 (13.9)

15 (28.8)
11 (21.2)

7 (24.2)
8 (24.2)

18 (47.4)
7 (18.5)

21 (58.3)
10 (27.8)

160

14 (26.4)

16 (48.5)

17 (44.7)

12 (33.3)

160

24 (45.3)

12 (36.4)

16 (42.1)

12 (36.1)

160

15 (28.3)

10 (30.3)

11 (28.9)

12 (33.3)

154

* Post hoc comparisons using the Bonferroni correction indicated that for both genders there was a
significance between the first three quartiles and 100th HGS quartile (p <0.001)
** Indicates level of significance between the median HGS for each quartile.

Quality of life analysis by HGS categories
The mean global health status/QoL score of the cohort was 65.7 ± 21.2, with a possible
maximum score of 100. This score was significantly lower in patients with weaker HGS
(<0.001). This was also true for physical, role, emotional and cognitive functioning
(<0.001). For symptom scales, scores with a higher result indicated a higher symptom
burden. The highest symptom scores were for fatigue (mean±SD: 32.9 ± 26.7), and there
was a significant difference in the fatigue scores between the two HGS groups (<0.001).
Pain and appetite loss were also significantly higher in those with weaker HGS (<0.001).
(Table 2)
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Table 3: The EORTC QLQ-C30 quality of life scales for the total group and by normal and weak HGS
groups

Weak HGS
Normal HGS
(dynapenia)
n = 117
P-value
n= 43

EORTC QLQ-C30 Scales

Total
n=160

Global health status / QoL

65.7 ± 21.2

67.9 ± 20.8

59.5 ± 21.4

<0.001

Physical functioning
Mean (SD)

78.5 ± 20.8

80.9 ± 19.5

71.4 ± 23.0

<0.001

74 ± 29.3

76.8 ± 27.3

65.5 ± 33.3

<0.001

79.3 ± 22.9

84.5 ± 21.0

75.7 ± 27.3

<0.001

80.5 ± 22.9

100 (33.3)

83.3 (33.3)

<0.001

74 ± 27.9

83.3 (33.3)

83.3 (33.3)

0.06

32.9 ± 26.7

29.2 ± 25.9

42.3 ± 26.6

<0.001

8.3 ± 19

8.7 ± 20.4

7.5 ± 20.4

0.25

20.8 ± 30.6

17.0 ± 27.9

32.2 ± 35.4

<0.001

18.6 ± 25.5

17.8 ± 26.0

20.6 ± 24.4

0.98

31 ± 36.7

29.4 ± 36.2

36.5 ± 38.1

0.94

14.6 ± 27.2

10.5 ± 23.4

26.4 ± 33.5

<0.001

14 ± 27.6

12.0 ± 25.0

19.8 ± 33.8

0.52

10 ± 22.4

10.5 ± 22.6

8.7 ± 22.2

0.37

14.6 ± 24.7

16.0 ± 25.0

11.1 ± 24.0

0.40

Role functioning
Mean (SD)
Emotional functioning
Mean (SD)
Cognitive functioning
Median (IQR)
Social functioning
Median (IQR)
Symptom Scales**
Fatigue
Mean (SD)
Nausea/vomiting
Mean (SD)
Pain
Mean (SD)
Dyspnoea
Mean (SD)
Insomnia
Mean (SD)
Appetite loss
Mean (SD)
Constipation
Mean (SD)
Diarrhoea
Mean (SD)
Financial difficulties
Mean (SD)

*For functional scales and QoL, higher scores indicate higher functioning.
**For symptom scales, higher scores indicate impaired functioning
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4. Discussion
This study identified dynapenia in over a quarter (26.9%) of our cohort of ambulatory
oncology patients in the West of Ireland. Predominantly, those with weaker HGS were
female (54.8%) and still receiving treatment (62.1%). Our findings highlight that weak
HGS can be present in ambulatory oncology patients, and this can be associated with
decreased QoL characteristics. Those with weaker HGS had impaired physical, role,
emotional and cognitive functioning (all p<0.001) and were more likely to experience
fatigue, pain, and appetite loss (all p<0.001). This study reports similar findings to a
recent oncology study (n=158) where 23.4% had dynapenia present. (Rechinelli et al.,
2020). In Rechinelli et al’s study, the cohort had an average age of 59.5 ± 14.0 year and
used the same dynapenia cut-off points as defined in our study (women < 16 kg and for
men < 27 kg).
Previous studies show how low HGS is prevalent (70%) in admitted advanced cancer
inpatients (Kilgour et al., 2013; Norman et al., 2010), in 64.2% of older cancer patients
(mean age 79 years) (Lycke et al., 2019), in 32.8% cancer patients following surgery
(Sato et al., 2015; Chen et al., 2011) and in approximately 20% of cancer survivors (Paek
and Choi, 2019; Benavides-Rodríguez et al., 2017). The findings of this study are
relevant in the field of oncology as there is a lack of data on HGS in ambulatory oncology
patients and early detection could aid combat any negative malnutrition effects such as
increased length of stay in hospital (Kruizenga et al., 2016), increased risk of post‐
surgery complications (Sathianathen et al., 2019) and decrease in response to treatment
(Capuano et al., 2010), all of which can impact QoL. Lack of data – need for research to
determine – impact. Clinically
As evident in the literature, cancer is negatively associated with QoL (Capuano et al.,
2010). The mean Global Health Status score in our cohort was 65.7 ± 21.2, which is
slightly higher than the reference value of 61.3 ± 24.2 provided by the EORTC (for all
cancer types and all stages) (Scott et al., 2008). This was significantly different between
those with normal HGS and weak HGS. Our findings also show those with weaker HGS
scored significantly lower on physical, role, emotional and cognitive functioning scales
(all p<0.001). Comparable, Kilgour et al., had findings of decreased QoL and physical
functioning scores in cancer patients with the weakest HGS, however this was in
advanced oncology patients, and it used the McGill QoL questionnaire (Kilgour et al.,
2013). In a study conducted by Norman et al patients with GI tract cancer cachexia had
lower HGS which correlated to lower QoL status and decreased physical functioning
(Norman et al., 2012).
In our cohort, those with weak HGS had statistically significantly higher scores for three
(fatigue, pain, and appetite loss) symptom scales of the EORTC QLQ-C30. Of these
symptoms, fatigue was the most prevalent symptom for the whole cohort, but it
particularly affected those with dynapenia. In oncology, cancer related fatigue (CRF) is
the most common and debilitating of symptoms experienced by patients, affecting 5090% of cancer patients (Charalambous and Kouta, 2016; Ann et al., 2015; Campos et al.,
2011). In a cross-sectional qualitative study on CRF and quality of life, patients
undergoing chemotherapy described the profound impacts on their lives that were
reflected through the following themes: “dependency on others,” “loss of power over
decision making,” and “daily living disruption” (Charalambous and Kouta, 2016). Over
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two-thirds of our cohort were still receiving chemotherapy which can intensify the impact
of CRF (Thong et al., 2020).
The term “appetite loss” is often observed as an indicator of QoL in oncology (Shragge
et al., 2006). Appetite loss is independently associated with survival and links to physical
function (Lis, Gupta, and Grutsch, 2008). In this study, the appetite loss score was twofold higher in patients with the weaker HGS. This nutritional impairment can adversely
affect dietary intake, which can lead to loss of muscle mass and strength and
consequently, to a deterioration of nutritional status (Clark and Manini, 2012).
Regarding clinical implications, reduced strength in oncology is associated with
malnutrition (Balci et al., 2018), weight loss (Ryan et al., 2019), sarcopenia (Ryan et al.,
2019), pre-cachexia, cancer cachexia (Ryan et al., 2016) and mortality (Chen et al.,
2011). If hand grip dynamometry was introduced as a proxy to identify cancer patients
with reduced strength, it could aid timely referral for support in a clinical setting before
the likelihood of clinical implications such as longer hospital stays, reduced functional
capacity and loss of independence (Deutz et al., 2019). Targeted multimodal
interventions are recommended, cancer rehabilitation programs have successfully shown
how exercise and strength training are effective improving muscular strength
(Christensen et al., 2014). A recent study investigated the success of strength training in
health related QoL in women with newly diagnosed breast cancer, the results of the study
showed how the training was well tolerated and safe, improving overall strength,
increasing QoL by 13% and reducing fatigue by 25% (Ceseiko et al., 2019). In another
study, in prostate cancer patients, upper body strength improved by 22% after 24 weeks
of resistance training, and after 17 weeks of strength training early-stage breast cancer
patients improved strength by 25-35% (Courneya et al., 2007; Segal et al., 2009).
Norman et al., carried out a three-month nutritional intervention with protein and energy
rich supplements in malnourished GI patients, with a control group given only dietary
advice. Results showed functional status, HGS and QoL improved in the intervention
group (Norman et al., 2008).
Current recommendations for protein in cancer patients is 1-1.5g/kg/d (Arends et al.,
2017); evidence shows how 50% of cancer patients do not meet this recommendation
(Prado et al., 2012). A noteworthy finding in our study was since cancer diagnosis, 70%
of the total cohort report receiving no nutritional advice from a registered dietitian, with
36.9% and 40.6% reporting weight loss and gain, respectively. Additionally, in a recent
national oncology study 52% of the cohort self-reported personal muscle loss (Sullivan
et al., 2021). Combined, these results emphasize and reflect the urgent need for more
registered oncology dietitians in Ireland, as currently there is one dietitian per 4,500
oncology patients.
This study had several limitations, a heterogeneous cohort resulted in differences in
cancer type, time since diagnosis and the clinic attended. However, this heterogeneity is
a representation of regular clinical practice, and highlights how the use of HGS in
identifying patients at risk of a poorer QoL can be utilized in a real-world clinical setting.
The participants were predominately female, this factor was out of our control, as more
females presented in the clinics than males. There was an imbalance in the number of
patients recruited from the oncology day ward and outpatients. If the study was to be
repeated, higher numbers of outpatients should be included if possible, however time
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spent on site is much lower for outpatients, making recruitment in this setting more
challenging. In addition, more patients presented in the oncology day ward. The study
did not collect direct information regarding exercise or physical activity, however,
EORTC QLQ-C30 incorporates this into the functioning scales. As this was a cross‐
sectional study, the aetiology of weak HGS cannot be confirmed; furthermore, some
participants may have just started or finished treatment, which could have influenced
muscle strength and their nutritional status may have changed quite quickly in the
proceeding months.

5. Conclusions
This study found a 26.9% prevalence of dynapenia in a cohort of Irish ambulatory cancer
patients and that this was associated with impaired physical, role and cognitive
functioning and increased symptom burden scores for fatigue, pain, and appetite loss.
Early detection by incorporation of routine screening of muscle strength in clinical
practice has the capability of identifying patients at risk of poorer clinical implications.
This has the potential to aid timely referral to nutrition support or resistance training,
which could lead to improvement of muscle strength, maintaining functional
independence, and subsequently enhancing quality of life.

6. Future Work
Previously discussed research studies showed how the measurement of HGS could be a
part of daily clinical practice, as it is inexpensive, reliable, and feasible in routine practice
(Bohannon, 2015). Future work should determine if the early identification of weak
muscle strength by grip strength could be improved by timely referral to resistance
training and nutritional support and the long-term clinical impacts this could have should
be measured.
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